Ferreira-Hermosillo Aldo, Molina-Ayala Mario, Ramírez-Rentería Claudia, Vargas Guadalupe, Gonzalez Baldomero, Isibasi Armando, Archundia-Riveros Irma, Mendoza Victoria
Endocrinology Department, Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, MEX, Mexico.
Experimental Endocrinology Investigation Unit, Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, MEX, Mexico.
J Diabetes Res. 2015;2015:972073. doi: 10.1155/2015/972073. Epub 2015 Jul 27.
To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups.
We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features.
We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups.
We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (n = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS.
. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance.
比较伴有和不伴有代谢综合征的1型糖尿病患者血清白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子(TNF)、白细胞介素-8(IL-8)、抵抗素和脂联素的浓度,并确定能准确区分这些组别的估计葡萄糖处置率的切点。
我们对2012年1月至2013年1月在我们的1型糖尿病诊所的所有患者进行了横断面评估。当患者符合联合声明标准时,被认为患有代谢综合征,并对其临床、生化和免疫特征进行评估。
我们用流式细胞术测定了伴有和不伴有代谢综合征患者的血清IL-6、IL-8、IL-10和TNF,并用酶联免疫吸附测定法测定了脂联素和抵抗素的浓度。我们还比较了各组之间的估计葡萄糖处置率。
我们测试了140名患者。44%的患者符合代谢综合征标准(n = 61),54%有中心性肥胖,30%有高甘油三酯血症,29%有低高密度脂蛋白血症,19%有高血压。我们观察到患有代谢综合征的患者抵抗素浓度较高。
我们发现墨西哥1型糖尿病患者中代谢综合征的患病率很高。抵抗素水平升高可能与脂肪量增加有关,并可能参与胰岛素抵抗的发生发展。